BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.8%

Neg 0% Neu 87.8% Pos 0%

BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.

Comments

No comments yet. Be the first!